Albanese, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 5.927
EU - Europa 5.583
AS - Asia 5.161
SA - Sud America 1.458
AF - Africa 142
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
Totale 18.294
Nazione #
US - Stati Uniti d'America 5.769
SG - Singapore 2.382
DE - Germania 1.902
CN - Cina 1.433
BR - Brasile 1.207
SE - Svezia 849
UA - Ucraina 701
IT - Italia 432
FR - Francia 427
IE - Irlanda 378
VN - Vietnam 311
ID - Indonesia 242
GB - Regno Unito 226
IN - India 195
RU - Federazione Russa 184
FI - Finlandia 158
TR - Turchia 115
AR - Argentina 96
HK - Hong Kong 87
BD - Bangladesh 86
AT - Austria 71
MX - Messico 57
JP - Giappone 56
CA - Canada 55
IQ - Iraq 49
PL - Polonia 49
EC - Ecuador 46
NL - Olanda 39
ZA - Sudafrica 35
BE - Belgio 28
CI - Costa d'Avorio 27
CO - Colombia 27
ES - Italia 27
PK - Pakistan 25
SA - Arabia Saudita 20
UZ - Uzbekistan 20
MA - Marocco 18
PE - Perù 18
VE - Venezuela 18
CL - Cile 16
KR - Corea 15
IR - Iran 13
AU - Australia 12
DZ - Algeria 12
EG - Egitto 12
PY - Paraguay 12
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
BG - Bulgaria 10
IL - Israele 10
JO - Giordania 10
KE - Kenya 10
RO - Romania 10
GR - Grecia 9
NP - Nepal 9
PA - Panama 9
BO - Bolivia 8
CR - Costa Rica 8
CZ - Repubblica Ceca 8
EE - Estonia 8
KZ - Kazakistan 8
LT - Lituania 8
UY - Uruguay 8
HN - Honduras 7
HU - Ungheria 7
OM - Oman 7
AZ - Azerbaigian 6
CH - Svizzera 6
JM - Giamaica 6
MD - Moldavia 6
SI - Slovenia 6
DK - Danimarca 5
EU - Europa 5
NO - Norvegia 5
TW - Taiwan 5
AL - Albania 4
AM - Armenia 4
BH - Bahrain 4
ET - Etiopia 4
KW - Kuwait 4
LB - Libano 4
MY - Malesia 4
PH - Filippine 4
QA - Qatar 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
BN - Brunei Darussalam 2
BZ - Belize 2
GA - Gabon 2
Totale 18.263
Città #
Singapore 901
Chandler 869
Ashburn 753
Dublin 376
San Mateo 338
Jacksonville 321
Beijing 281
Jakarta 217
Nanjing 207
Wilmington 179
New York 140
Hefei 124
Boston 119
Dallas 117
Lawrence 116
Dearborn 113
Los Angeles 109
Ann Arbor 106
Ho Chi Minh City 105
Moscow 103
Woodbridge 102
São Paulo 94
Houston 85
Nürnberg 85
Princeton 85
Redwood City 85
Hong Kong 82
Milan 82
Hanoi 76
Izmir 76
Nanchang 68
Shenyang 66
Lancaster 61
Cattolica 60
Seattle 60
Frankfurt am Main 52
Fairfield 51
Norwalk 49
Buffalo 48
Mountain View 48
University Park 45
Bremen 41
Munich 40
Jiaxing 39
Tianjin 39
Chicago 38
Hangzhou 38
Changsha 36
Detroit 35
Hebei 35
Rio de Janeiro 35
Marseille 34
Redmond 34
Kunming 33
Tokyo 33
Rome 32
Boardman 31
Pune 31
Brussels 28
Abidjan 27
Kent 26
Nuremberg 23
Zhengzhou 23
Belo Horizonte 22
Brasília 22
Brooklyn 22
Curitiba 22
London 22
Santa Clara 21
Falls Church 19
Johannesburg 19
Kraków 19
Simi Valley 19
Warsaw 19
Guangzhou 18
Phoenix 18
Tashkent 18
Dhaka 17
Chennai 16
Montreal 16
Atlanta 15
Baghdad 15
Campinas 15
Ningbo 15
San Francisco 15
Stockholm 15
Washington 15
Ypsilanti 15
Denver 14
Guayaquil 14
Leawood 14
Seoul 14
Fremont 13
Haiphong 13
Lima 13
Quito 13
Düsseldorf 12
Fortaleza 12
Shanghai 12
Busto Arsizio 11
Totale 8.389
Nome #
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 354
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 184
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 183
Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease 176
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease 175
Mutation screening of the DYT6/THAP1 gene in Italy 173
Organization of central nervous system dopaminergic pathways 169
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 163
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation 156
Relationships between disability, quality of life and prevalence of nonmotor symptoms in Parkinson's disease 153
Phenotypic characterisation of DYT13 primary torsion distonia. 148
Botulinum toxin in the treatment of outlet obstruction constipation due to puborectalis syndrome 143
Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease 143
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs 142
Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. 140
Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia. Results of a randomised, placebo-controlled study. 139
Clinical and genetic characteristics of late-onset Huntington's disease 139
Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up 134
Analysis of blink rate in patients with blepharospasm 130
Advances in the genetics of primary torsion dystonia 128
Early DEtection of wEaring off in Parkinson disease: the DEEP study 128
Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature 126
A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. 125
Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease 124
Bilateral high frequency subthalamic stimulation in Parkinson's disease: long-term neurological follow-up 123
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 123
Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A. 122
Botulinum toxin injected in the gastric wall reduces body weight and food intake rats. 121
Alpha-synuclein gene duplication: marked intrafamilial variability in two novel pedigrees 121
Attentional networks in Parkinson's disease 120
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm 119
Behavioral and personality features in patients with lateralized Parkinson's disease 118
PINK1 mutations are associated with sporadic early-onset parkinsonism. 118
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson’s disease: Need for long-term trials. 117
Choice-option evaluation is preserved in early Huntington and Parkinson's disease 117
Abnormal gating of somatosensory inputs in essential tremor. 116
Motor features and response to oral levodopa in patients with Parkinson's disease under continuous dopaminergic infusion or deep brain stimulation 116
Phenomenology and classification of dystonia: a consensus update 116
Botulinum neurotoxin to treat chronic anal fissure: results of a randomized "Botox vs Dysport" controlled trial. 112
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders 111
Gastroenterologia. 110
Dystonic tremor 110
Onset and progression of primary torsion dystonia in sporadic and familial cases 109
Subclinical sensory abnormalities in unaffected PINK1 heterozygotes 109
Isolated cervical dystonia: diagnosis and classification 108
Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation 108
Smooth muscle spasms and sphincters. 107
Management of bladder, prostatic and pelvic floor disorders 107
Botulinum neurotoxins for post-stroke spasticity in adults: A systematic review. 107
Non-motor effects of deep brain stimulation of the subthalamic nucleus in Parkinson's disease. 106
Primary dystonias 106
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis 106
A 52-Year-Old Man with Myoclonic Jerks 106
Isolated limb dystonia as presenting feature of Parkin disease 106
Dystonia: diagnosis and management 106
DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13-36.32 in a Italian family with cranial-cervical or upper limb onset. 105
A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome 104
EFNS guidelines on diagnosis and treatment of primary dystonias 104
Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease 101
Dystonia rating scales: critique and recommendations 101
Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincter spasms. 100
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration 100
Primary focal hyperhidrosis in a new family not linked to known loci 99
Aging is associated with a diffuse impairment of forebrain cholinergic neurons 99
Hereditary early-onset Parkinson's disease caused by mutations in PINK1. 98
Choline acetyltransferase (ChAT) activity differs in right and left human temporal lobes 96
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease 96
Genome-wide association study in musician's dystonia: A risk variant at the arylsulfatase G locus? 95
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis 95
Peripheral neuropathy in the course of progressive systemic sclerosis: light and ultrastructural study 94
Correction to: The Italian Dystonia Registry: rationale, design and preliminary findings (Neurological Sciences, (2017), 38, 5, (819-825), 10.1007/s10072-017-2839-3) 94
Dihydroergocriptine in Parkinson's disease: clinical efficacy and comparison with other dopamine agonists. 91
Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease 91
Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation 91
Quantitative gait analysis in parkin disease: Possible role of dystonia 91
Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study 91
Idiopathic delayed-onset edema surrounding deep brain stimulation leads: Insights from a case series and systematic literature review 91
Is this dystonia? 90
Shifting from constant-voltage to constant-current in Parkinson's disease patients with chronic stimulation 90
Pathological gambling in Parkinson's disease: subthalamic oscillations during economics decisions 89
Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. 88
Subthalamic involvement in monetary reward and its dysfunction in parkinsonian gamblers 88
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 88
Design and Operation of the Lombardy Parkinson's Disease Network 88
Role of the dopamine D5 receptor (DRD5) as a susceptibility gene for cervical dystonia. 87
Cholinergic and non-cholinergic forebrain projections to the interpeduncular nucleus 86
Effectiveness of higher doses of botulinum toxin to induce healing in patients eith chronic anal fissure. 86
Age-dependent loss of cholinergic neurones in basal ganglia of rats 86
Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36 86
Impulse control behavior in GBA-mutated parkinsonian patients 86
Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement 85
Expert recommendations for diagnosing cervical, oromandibular, and limb dystonia 85
Early visual memory deficits: a neuropsychological marker of GBA mutations in PD? 84
Dystonia and tremor: the clinical syndromes with isolated tremor 84
Failure of pallidal deep brain stimulation in DYT12-ATP1A3 dystonia 84
Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy 84
Therapeutic advances in dystonia 83
Oromandibular dystonia: from onset to spread a multicenter italian study 82
Organization of the ascending projections from the ventral tegmental area: a multiple fluorescent retrograde tracer study in the rat 82
Correlation of cardiovascular autonomic function tests, magnetic resonance brain imaging and clinical features in suspect cases of multiple system atrophy 82
Totale 11.376
Categoria #
all - tutte 87.926
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.926


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021735 0 0 0 0 0 50 188 20 179 60 216 22
2021/20221.348 191 157 22 45 47 32 21 271 48 59 211 244
2022/20232.567 354 345 231 353 229 303 99 177 325 31 91 29
2023/20241.537 47 493 43 241 42 139 78 43 22 57 161 171
2024/20252.796 66 90 261 56 176 82 78 105 543 215 562 562
2025/20264.614 1.348 264 621 882 1.170 329 0 0 0 0 0 0
Totale 18.462